Health Care
Commentary
Don’t be fooled by Biden’s victory lap on Obamacare
The U.S. Department of Health and Human Services just released a report asserting that 31 million people now have insurance coverage thanks to the Affordable Care Act. That would be a record, an increase of nearly 4 million from 2020. That headline number could go up in the months to come. But the growth ...
Commentary
COVID-19 Vaccines Will Not Be Enough. We Also Need Effective Treatments
The COVID-19 vaccines have been nothing short of miraculous. Life is returning to normal in many places. But ACSH advisor Dr. Henry Miller argues that we will still need effective medical treatments for COVID-19. COVID-19 vaccines are the miracle that has significantly suppressed the pandemic in a number of countries, ...
Coronavirus
Dr. Henry Miller Joins the John Batchelor Show to Discuss Coronavirus Research
Dr. Henry Miller, physician, molecular biologist, and PRI senior fellow joins the John Batchelor Show to discuss what the scientific community has learned about the family of coronaviruses, what’s next for COVID-19 treatments and vaccines, and how humans have fared under different forms of the coronavirus.
Featured
Read Sally Pipes’ Remarks from Adam Smith Society National Meeting
Below are remarks delivered by PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy Sally C. Pipes at the annual national meeting of the Adam Smith Society on June 9, 2021. She spoke about free market health care solutions. Thank you so very much for inviting me ...
Commentary
What’s Really at Stake in the Supreme Court Obamacare Challenge
The U.S. Supreme Court is set to issue its ruling in California v. Texas, the latest case challenging the constitutionality of Obamacare, later this month. The conventional wisdom holds that the high court will uphold the law. But that’s no sure thing. Regardless of what the court decides, Obamacare has failed on ...
Blog
To See the Fallacy of H.R. 3 (Lower Drug Costs Now Act) Just Look at the Inflation Data
Railing about sky high drug prices makes good political theater and helps drum up support for the latest attempt to impose drug price controls (H.R. 3 or the Lower Drug Costs Now Act). This accusation also perpetuates misinformation. If implemented, H.R. 3 would endanger patient access to current efficacious medicines ...
Commentary
The White House Continues Its Campaign To Deny People Insurance Choices
The Biden administration is continuing its onslaught against health plans that don’t have their seal of approval. At a congressional hearing last month, Secretary of Health and Human Services Xavier Becerra agreed with Rep. Kathy Castor’s, D-Fla., characterization of short-term health plans as “junk” insurance—and promised to scrutinize a Trump-era rule ...
Commentary
Democrats Ask All the Wrong Questions About the Public Option
The public option is back on the congressional docket. Last week, Rep. Frank Pallone Jr., D-N.J., the head of the House Energy and Commerce Committee, and Sen. Patty Murray, D-Wash., who helms the Senate Health, Education, Labor, and Pensions Committee, issued an open request for information on how to implement a ...
Obamacare
Erik Jaffe – The U.S. Supreme Court Cases this Session
The featured guest for this podcast Erik Jaffe, partner at Schaerr Jaffe, a constitutional lawyer, and a PRI fellow in Legal Studies. Erik takes us through a tour of the major U.S. Supreme Court cases this session and the constitutional issues in question, from Obamacare to the First Amendment. Erik ...
Blog
Newsom’s “Comeback” Plan for Small Businesses
Back in February, Tim Anaya and I interviewed for PRI’s Next Round podcast Cynthia Ariosta and Carl Dene, small business owners in Napa Valley, to get their perspective on Gov. Newsom’s COVID restrictions on small businesses. This heart-wrenching interview was one of our most listened to podcasts this year. In ...
Don’t be fooled by Biden’s victory lap on Obamacare
The U.S. Department of Health and Human Services just released a report asserting that 31 million people now have insurance coverage thanks to the Affordable Care Act. That would be a record, an increase of nearly 4 million from 2020. That headline number could go up in the months to come. But the growth ...
COVID-19 Vaccines Will Not Be Enough. We Also Need Effective Treatments
The COVID-19 vaccines have been nothing short of miraculous. Life is returning to normal in many places. But ACSH advisor Dr. Henry Miller argues that we will still need effective medical treatments for COVID-19. COVID-19 vaccines are the miracle that has significantly suppressed the pandemic in a number of countries, ...
Dr. Henry Miller Joins the John Batchelor Show to Discuss Coronavirus Research
Dr. Henry Miller, physician, molecular biologist, and PRI senior fellow joins the John Batchelor Show to discuss what the scientific community has learned about the family of coronaviruses, what’s next for COVID-19 treatments and vaccines, and how humans have fared under different forms of the coronavirus.
Read Sally Pipes’ Remarks from Adam Smith Society National Meeting
Below are remarks delivered by PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy Sally C. Pipes at the annual national meeting of the Adam Smith Society on June 9, 2021. She spoke about free market health care solutions. Thank you so very much for inviting me ...
What’s Really at Stake in the Supreme Court Obamacare Challenge
The U.S. Supreme Court is set to issue its ruling in California v. Texas, the latest case challenging the constitutionality of Obamacare, later this month. The conventional wisdom holds that the high court will uphold the law. But that’s no sure thing. Regardless of what the court decides, Obamacare has failed on ...
To See the Fallacy of H.R. 3 (Lower Drug Costs Now Act) Just Look at the Inflation Data
Railing about sky high drug prices makes good political theater and helps drum up support for the latest attempt to impose drug price controls (H.R. 3 or the Lower Drug Costs Now Act). This accusation also perpetuates misinformation. If implemented, H.R. 3 would endanger patient access to current efficacious medicines ...
The White House Continues Its Campaign To Deny People Insurance Choices
The Biden administration is continuing its onslaught against health plans that don’t have their seal of approval. At a congressional hearing last month, Secretary of Health and Human Services Xavier Becerra agreed with Rep. Kathy Castor’s, D-Fla., characterization of short-term health plans as “junk” insurance—and promised to scrutinize a Trump-era rule ...
Democrats Ask All the Wrong Questions About the Public Option
The public option is back on the congressional docket. Last week, Rep. Frank Pallone Jr., D-N.J., the head of the House Energy and Commerce Committee, and Sen. Patty Murray, D-Wash., who helms the Senate Health, Education, Labor, and Pensions Committee, issued an open request for information on how to implement a ...
Erik Jaffe – The U.S. Supreme Court Cases this Session
The featured guest for this podcast Erik Jaffe, partner at Schaerr Jaffe, a constitutional lawyer, and a PRI fellow in Legal Studies. Erik takes us through a tour of the major U.S. Supreme Court cases this session and the constitutional issues in question, from Obamacare to the First Amendment. Erik ...
Newsom’s “Comeback” Plan for Small Businesses
Back in February, Tim Anaya and I interviewed for PRI’s Next Round podcast Cynthia Ariosta and Carl Dene, small business owners in Napa Valley, to get their perspective on Gov. Newsom’s COVID restrictions on small businesses. This heart-wrenching interview was one of our most listened to podcasts this year. In ...
